中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
12期
65-66,67
,共3页
神经节苷脂%新生儿缺血缺氧性脑病%治疗效果
神經節苷脂%新生兒缺血缺氧性腦病%治療效果
신경절감지%신생인결혈결양성뇌병%치료효과
Ganglioside%Neonatal hypoxic ischemia encephalopathy%Treatment effect
目的:探究经节苷脂在新生儿缺血缺氧性脑病(HIE)患儿治疗中的作用。方法:选取2013年6月-2014年6月在本院住院治疗的120例HIE患儿作为研究对象,随机数字表法均分为试验组和对照组,对照组患儿采取常规治疗,试验组在常规治疗的基础上采用神经节苷脂进行治疗。观察两组治疗后的疗效、临床症状恢复正常的时间等指标。结果:试验组治疗后的总有效率明显提高,临床症状恢复时间缩短,DQ得分提高,血浆NSE水平降低,与对照组比较差异均有统计学意义(P<0.05)。结论:神经节苷脂在治疗新生儿缺血缺氧性脑病上具有明显的临床效果,能提高临床治疗效果,值得进一步推广和使用。
目的:探究經節苷脂在新生兒缺血缺氧性腦病(HIE)患兒治療中的作用。方法:選取2013年6月-2014年6月在本院住院治療的120例HIE患兒作為研究對象,隨機數字錶法均分為試驗組和對照組,對照組患兒採取常規治療,試驗組在常規治療的基礎上採用神經節苷脂進行治療。觀察兩組治療後的療效、臨床癥狀恢複正常的時間等指標。結果:試驗組治療後的總有效率明顯提高,臨床癥狀恢複時間縮短,DQ得分提高,血漿NSE水平降低,與對照組比較差異均有統計學意義(P<0.05)。結論:神經節苷脂在治療新生兒缺血缺氧性腦病上具有明顯的臨床效果,能提高臨床治療效果,值得進一步推廣和使用。
목적:탐구경절감지재신생인결혈결양성뇌병(HIE)환인치료중적작용。방법:선취2013년6월-2014년6월재본원주원치료적120례HIE환인작위연구대상,수궤수자표법균분위시험조화대조조,대조조환인채취상규치료,시험조재상규치료적기출상채용신경절감지진행치료。관찰량조치료후적료효、림상증상회복정상적시간등지표。결과:시험조치료후적총유효솔명현제고,림상증상회복시간축단,DQ득분제고,혈장NSE수평강저,여대조조비교차이균유통계학의의(P<0.05)。결론:신경절감지재치료신생인결혈결양성뇌병상구유명현적림상효과,능제고림상치료효과,치득진일보추엄화사용。
Objective:To explore the fat in a role in the treatment of children with neonatal hypoxic ischemia encephalopathy.Method:120 children with HIE were selected as the research object, the patients were randomly divided into two groups, the experimental group of patients on the basis of routine therapy used ganglioside treatment, control group children take regular treatment.The curative effect of patients after treatment, clinical symptoms returned to normal time and so on were investigated.Result:After treatment,the effect was obviously improved, the recovery time of clinical symptom was shorten, and DQ scores was improved, serum NSE levels was lower too of the experimental group, compared with the control group differences were statistically significant (P<0.05).Conclusion:The ganglioside in the treatment of neonatal hypoxic ischemia encephalopathy has obvious clinical effect, can improve the effect of clinical treatment, is worth further promotion and use.